Summit Global Investments’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Summit Global Investments's RDY Position: Q2 2026 in Review
Summit Global Investments sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 53,845 shares — an estimated $746K sold.
Summit Global Investments first reported a position in RDY in Q1 2022 and held it in 17 quarters. The position peaked at $2.46M in Q4 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Summit Global Investments reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
- Summit Global Investments sold 53,845 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $746K.
- Summit Global Investments first reported a position in Dr. Reddy's Laboratories in Q1 2022 and held it in 17 quarters.
- Summit Global Investments's Dr. Reddy's Laboratories position peaked at $2.46M in Q4 2023.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.